SIGLEC1 and breast carcinoma: These previous results are here supported by data using the TCGA database in R2: Genomics Analysis and Visualization platform (www.hgserver1.amc.nl), where high mRNA expression levels of SIGLEC1 in primary human breast cancers correlated significantly with worse overall survival (Figure 1A) (P=0.020).